Private equity firms who hold 39% of Lyra Therapeutics, Inc.

Private equity firms who hold 39% of Lyra Therapeutics, Inc. (NASDAQ:LYRA) gained 6.8%, institutions profited as well

Key Insights Significant control over Lyra Therapeutics by private equity firms implies that the general public has...

Related Keywords

, Lyra Therapeutics Inc , Perceptive Advisors , Lyra Therapeutics , Private Equity Firms , Shareholders ,